Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 78

1.

Increased ENaC activity during kidney preservation in Wisconsin solution.

Khedr S, Palygin O, Pavlov TS, Blass G, Levchenko V, Alsheikh A, Brands MW, El-Meanawy A, Staruschenko A.

BMC Nephrol. 2019 Apr 29;20(1):145. doi: 10.1186/s12882-019-1329-7.

2.

ATP release into ADPKD cysts via pannexin-1/P2X7 channels decreases ENaC activity.

Arkhipov SN, Pavlov TS.

Biochem Biophys Res Commun. 2019 May 21;513(1):166-171. doi: 10.1016/j.bbrc.2019.03.177. Epub 2019 Apr 2.

3.

Salt-deficient diet exacerbates cystogenesis in ARPKD via epithelial sodium channel (ENaC).

Ilatovskaya DV, Levchenko V, Pavlov TS, Isaeva E, Klemens CA, Johnson J, Liu P, Kriegel AJ, Staruschenko A.

EBioMedicine. 2019 Feb;40:663-674. doi: 10.1016/j.ebiom.2019.01.006. Epub 2019 Feb 8.

4.

Characterization of purinergic receptor expression in ARPKD cystic epithelia.

Palygin O, Ilatovskaya DV, Levchenko V, Klemens CA, Dissanayake L, Williams AM, Pavlov TS, Staruschenko A.

Purinergic Signal. 2018 Dec;14(4):485-497. doi: 10.1007/s11302-018-9632-5. Epub 2018 Nov 11.

5.

A mutation affecting polycystin-1 mediated heterotrimeric G-protein signaling causes PKD.

Parnell SC, Magenheimer BS, Maser RL, Pavlov TS, Havens MA, Hastings ML, Jackson SF, Ward CJ, Peterson KR, Staruschenko A, Calvet JP.

Hum Mol Genet. 2018 Oct 1;27(19):3313-3324. doi: 10.1093/hmg/ddy223.

6.

β1Pix exchange factor stabilizes the ubiquitin ligase Nedd4-2 and plays a critical role in ENaC regulation by AMPK in kidney epithelial cells.

Ho PY, Li H, Pavlov TS, Tuerk RD, Tabares D, Brunisholz R, Neumann D, Staruschenko A, Hallows KR.

J Biol Chem. 2018 Jul 20;293(29):11612-11624. doi: 10.1074/jbc.RA118.003082. Epub 2018 Jun 1.

7.

A NOX4/TRPC6 Pathway in Podocyte Calcium Regulation and Renal Damage in Diabetic Kidney Disease.

Ilatovskaya DV, Blass G, Palygin O, Levchenko V, Pavlov TS, Grzybowski MN, Winsor K, Shuyskiy LS, Geurts AM, Cowley AW Jr, Birnbaumer L, Staruschenko A.

J Am Soc Nephrol. 2018 Jul;29(7):1917-1927. doi: 10.1681/ASN.2018030280. Epub 2018 May 23.

8.

Essential role of Kir5.1 channels in renal salt handling and blood pressure control.

Palygin O, Levchenko V, Ilatovskaya DV, Pavlov TS, Pochynyuk OM, Jacob HJ, Geurts AM, Hodges MR, Staruschenko A.

JCI Insight. 2017 Sep 21;2(18). pii: 92331. doi: 10.1172/jci.insight.92331. eCollection 2017 Sep 21.

9.

Lack of Effects of Metformin and AICAR Chronic Infusion on the Development of Hypertension in Dahl Salt-Sensitive Rats.

Pavlov TS, Levchenko V, Ilatovskaya DV, Li H, Palygin O, Pastor-Soler NM, Hallows KR, Staruschenko A.

Front Physiol. 2017 Apr 20;8:227. doi: 10.3389/fphys.2017.00227. eCollection 2017.

10.

Involvement of ENaC in the development of salt-sensitive hypertension.

Pavlov TS, Staruschenko A.

Am J Physiol Renal Physiol. 2017 Aug 1;313(2):F135-F140. doi: 10.1152/ajprenal.00427.2016. Epub 2016 Dec 21. Review.

11.

High salt diet and caffeine: food for thought.

Staruschenko A, Ilatovskaya DV, Pavlov TS.

J Thorac Dis. 2016 Oct;8(10):E1410-E1412. No abstract available.

12.

Regulation of Polycystin-1 Function by Calmodulin Binding.

Doerr N, Wang Y, Kipp KR, Liu G, Benza JJ, Pletnev V, Pavlov TS, Staruschenko A, Mohieldin AM, Takahashi M, Nauli SM, Weimbs T.

PLoS One. 2016 Aug 25;11(8):e0161525. doi: 10.1371/journal.pone.0161525. eCollection 2016.

13.

Renal sodium transport in renin-deficient Dahl salt-sensitive rats.

Pavlov TS, Levchenko V, Ilatovskaya DV, Moreno C, Staruschenko A.

J Renin Angiotensin Aldosterone Syst. 2016 Jul 21;17(3). pii: 1470320316653858. doi: 10.1177/1470320316653858. Print 2016 Jul.

14.

QSAR Toolbox - workflow and major functionalities.

Dimitrov SD, Diderich R, Sobanski T, Pavlov TS, Chankov GV, Chapkanov AS, Karakolev YH, Temelkov SG, Vasilev RA, Gerova KD, Kuseva CD, Todorova ND, Mehmed AM, Rasenberg M, Mekenyan OG.

SAR QSAR Environ Res. 2016 Mar;27(3):203-219. doi: 10.1080/1062936X.2015.1136680. Epub 2016 Feb 19.

PMID:
26892800
15.

Implementing Patch Clamp and Live Fluorescence Microscopy to Monitor Functional Properties of Freshly Isolated PKD Epithelium.

Pavlov TS, Ilatovskaya DV, Palygin O, Levchenko V, Pochynyuk O, Staruschenko A.

J Vis Exp. 2015 Sep 1;(103). doi: 10.3791/53035.

16.

UVCB substances: methodology for structural description and application to fate and hazard assessment.

Dimitrov SD, Georgieva DG, Pavlov TS, Karakolev YH, Karamertzanis PG, Rasenberg M, Mekenyan OG.

Environ Toxicol Chem. 2015 Nov;34(11):2450-62. doi: 10.1002/etc.3100. Epub 2015 Oct 8.

PMID:
26053589
17.

Cross-talk between insulin and IGF-1 receptors in the cortical collecting duct principal cells: implication for ENaC-mediated Na+ reabsorption.

Ilatovskaya DV, Levchenko V, Brands MW, Pavlov TS, Staruschenko A.

Am J Physiol Renal Physiol. 2015 Apr 1;308(7):F713-9. doi: 10.1152/ajprenal.00081.2014. Epub 2015 Jan 28.

18.

Impaired epithelial Na+ channel activity contributes to cystogenesis and development of autosomal recessive polycystic kidney disease in PCK rats.

Pavlov TS, Levchenko V, Ilatovskaya DV, Palygin O, Staruschenko A.

Pediatr Res. 2015 Jan;77(1-1):64-9. doi: 10.1038/pr.2014.145. Epub 2014 Oct 3.

19.

Role of Rho GDP dissociation inhibitor α in control of epithelial sodium channel (ENaC)-mediated sodium reabsorption.

Pavlov TS, Levchenko V, Staruschenko A.

J Biol Chem. 2014 Oct 10;289(41):28651-9. doi: 10.1074/jbc.M114.558262. Epub 2014 Aug 27.

20.

Epoxyeicosatrienoic acid analogue lowers blood pressure through vasodilation and sodium channel inhibition.

Hye Khan MA, Pavlov TS, Christain SV, Neckář J, Staruschenko A, Gauthier KM, Capdevila JH, Falck JR, Campbell WB, Imig JD.

Clin Sci (Lond). 2014 Oct;127(7):463-74. doi: 10.1042/CS20130479.

21.

Arp2/3 complex inhibitors adversely affect actin cytoskeleton remodeling in the cultured murine kidney collecting duct M-1 cells.

Ilatovskaya DV, Chubinskiy-Nadezhdin V, Pavlov TS, Shuyskiy LS, Tomilin V, Palygin O, Staruschenko A, Negulyaev YA.

Cell Tissue Res. 2013 Dec;354(3):783-92. doi: 10.1007/s00441-013-1710-y. Epub 2013 Sep 15.

22.

Orally active epoxyeicosatrienoic acid analog attenuates kidney injury in hypertensive Dahl salt-sensitive rat.

Hye Khan MA, Neckár J, Manthati V, Errabelli R, Pavlov TS, Staruschenko A, Falck JR, Imig JD.

Hypertension. 2013 Nov;62(5):905-13. doi: 10.1161/HYPERTENSIONAHA.113.01949. Epub 2013 Aug 26.

23.

Epidermal growth factors in the kidney and relationship to hypertension.

Staruschenko A, Palygin O, Ilatovskaya DV, Pavlov TS.

Am J Physiol Renal Physiol. 2013 Jul 1;305(1):F12-20. doi: 10.1152/ajprenal.00112.2013. Epub 2013 May 1. Review.

24.

Deficiency of renal cortical EGF increases ENaC activity and contributes to salt-sensitive hypertension.

Pavlov TS, Levchenko V, O'Connor PM, Ilatovskaya DV, Palygin O, Mori T, Mattson DL, Sorokin A, Lombard JH, Cowley AW Jr, Staruschenko A.

J Am Soc Nephrol. 2013 Jun;24(7):1053-62. doi: 10.1681/ASN.2012080839. Epub 2013 Apr 18.

25.

Real-time electrochemical detection of ATP and H₂O₂ release in freshly isolated kidneys.

Palygin O, Levchenko V, Ilatovskaya DV, Pavlov TS, Ryan RP, Cowley AW Jr, Staruschenko A.

Am J Physiol Renal Physiol. 2013 Jul 1;305(1):F134-41. doi: 10.1152/ajprenal.00129.2013. Epub 2013 Apr 17.

26.

Regulation of ENaC in mice lacking renal insulin receptors in the collecting duct.

Pavlov TS, Ilatovskaya DV, Levchenko V, Li L, Ecelbarger CM, Staruschenko A.

FASEB J. 2013 Jul;27(7):2723-32. doi: 10.1096/fj.12-223792. Epub 2013 Apr 4.

27.

G-protein signaling modulator 1 deficiency accelerates cystic disease in an orthologous mouse model of autosomal dominant polycystic kidney disease.

Kwon M, Pavlov TS, Nozu K, Rasmussen SA, Ilatovskaya DV, Lerch-Gaggl A, North LM, Kim H, Qian F, Sweeney WE Jr, Avner ED, Blumer JB, Staruschenko A, Park F.

Proc Natl Acad Sci U S A. 2012 Dec 26;109(52):21462-7. doi: 10.1073/pnas.1216830110. Epub 2012 Dec 10.

28.

ROS production as a common mechanism of ENaC regulation by EGF, insulin, and IGF-1.

Ilatovskaya DV, Pavlov TS, Levchenko V, Staruschenko A.

Am J Physiol Cell Physiol. 2013 Jan 1;304(1):C102-11. doi: 10.1152/ajpcell.00231.2012. Epub 2012 Nov 7.

29.

Regulation of TRPC6 Channels by Non-Steroidal Anti-Inflammatory Drugs.

Ilatovskaya DV, Pavlov TS, Negulyaev YA, Staruschenko A.

Biochem (Mosc) Suppl Ser A Membr Cell Biol. 2012 Jul;6(3):265-272. doi: 10.1134/S1990747812030063.

30.

[Mechanism of epithelial sodium channel (ENaC) regulation by cortactin: involvement of dynamin].

Ilatovskaia DV, Pavlov TS, Neguliaev IuA, Starushchenko AV.

Tsitologiia. 2011;53(11):903-10. Russian.

PMID:
22332421
31.

Effects of cytochrome P-450 metabolites of arachidonic acid on the epithelial sodium channel (ENaC).

Pavlov TS, Ilatovskaya DV, Levchenko V, Mattson DL, Roman RJ, Staruschenko A.

Am J Physiol Renal Physiol. 2011 Sep;301(3):F672-81. doi: 10.1152/ajprenal.00597.2010. Epub 2011 Jun 22.

32.

Cortical actin binding protein cortactin mediates ENaC activity via Arp2/3 complex.

Ilatovskaya DV, Pavlov TS, Levchenko V, Negulyaev YA, Staruschenko A.

FASEB J. 2011 Aug;25(8):2688-99. doi: 10.1096/fj.10-167262. Epub 2011 May 2.

PMID:
21536685
33.

Novel role of Rac1/WAVE signaling mechanism in regulation of the epithelial Na+ channel.

Karpushev AV, Levchenko V, Ilatovskaya DV, Pavlov TS, Staruschenko A.

Hypertension. 2011 May;57(5):996-1002. doi: 10.1161/HYPERTENSIONAHA.110.157784. Epub 2011 Apr 4.

PMID:
21464391
34.

Regulation of ENaC-Mediated Sodium Reabsorption by Peroxisome Proliferator-Activated Receptors.

Pavlov TS, Imig JD, Staruschenko A.

PPAR Res. 2010;2010:703735. doi: 10.1155/2010/703735. Epub 2010 Jun 14.

35.

Endothelin-1 inhibits the epithelial Na+ channel through betaPix/14-3-3/Nedd4-2.

Pavlov TS, Chahdi A, Ilatovskaya DV, Levchenko V, Vandewalle A, Pochynyuk O, Sorokin A, Staruschenko A.

J Am Soc Nephrol. 2010 May;21(5):833-43. doi: 10.1681/ASN.2009080885. Epub 2010 Mar 25.

36.

Intact cytoskeleton is required for small G protein dependent activation of the epithelial Na+ channel.

Karpushev AV, Ilatovskaya DV, Pavlov TS, Negulyaev YA, Staruschenko A.

PLoS One. 2010 Jan 21;5(1):e8827. doi: 10.1371/journal.pone.0008827.

37.

EGF and its related growth factors mediate sodium transport in mpkCCDc14 cells via ErbB2 (neu/HER-2) receptor.

Levchenko V, Zheleznova NN, Pavlov TS, Vandewalle A, Wilson PD, Staruschenko A.

J Cell Physiol. 2010 Apr;223(1):252-9. doi: 10.1002/jcp.22033.

PMID:
20049896
38.

Peroxisome proliferator-activated receptor gamma antagonists decrease Na+ transport via the epithelial Na+ channel.

Pavlov TS, Levchenko V, Karpushev AV, Vandewalle A, Staruschenko A.

Mol Pharmacol. 2009 Dec;76(6):1333-40. doi: 10.1124/mol.109.056911. Epub 2009 Sep 14.

PMID:
19752200
39.

Regulation of ENaC expression at the cell surface by Rab11.

Karpushev AV, Levchenko V, Pavlov TS, Lam V, Vinnakota KC, Vandewalle A, Wakatsuki T, Staruschenko A.

Biochem Biophys Res Commun. 2008 Dec 12;377(2):521-525. doi: 10.1016/j.bbrc.2008.10.014. Epub 2008 Oct 14.

40.

[A comparative analysis of distribution of glyprolines administered by various routes].

Ashmarin IP, Baglikova KE, Edeeva SE, Zolotarev IuA, Kozik VS, Dadaian AK, Dorokhova EM, Alfeeva LIu, Andreeva LA, Kopylova GN, Pavlov TS, Vas'kovskiĭ BV, Meshavkin VK, Sokolov OIu, Kost NV, Zozulia AA, Samonina GE, Miasoedov NF.

Bioorg Khim. 2008 Jul-Aug;34(4):464-70. Russian.

PMID:
18695718
41.

Selank and its metabolites maintain homeostasis in the gastric mucosa.

Pavlov TS, Samonina GE, Bakaeva ZV, Zolotarev YA, Guseva AA.

Bull Exp Biol Med. 2007 Jan;143(1):51-3.

PMID:
18019011
42.

[Evenly tritium-labeled peptides and their in vivo and in vitro biodegradation].

Zolotarev IuA, Dadaian AK, Dolotov OV, Kozik VS, Kost NV, Sokolov OIu, Dorokhova EM, Meshavkin VK, Inozemtseva LS, Gabaeva MV, Andreeva LA, Alfeeva LIu, Pavlov TS, Badmaeva KE, Badmaeva SE, Bakaeva ZV, Kopylova GN, Samonina GE, Vas'kovskiĭ BV, Grivennikov IA, Zozulia AA, Miasoedov NF.

Bioorg Khim. 2006 Mar-Apr;32(2):183-91. Russian.

PMID:
16637290
43.

POPs: a QSAR system for developing categories for persistent, bioaccumulative and toxic chemicals and their metabolites.

Mekenyan OG, Dimitrov SD, Pavlov TS, Veith GD.

SAR QSAR Environ Res. 2005 Feb-Apr;16(1-2):103-33.

PMID:
15844446
44.

[Effect of new synthetic anxiolytic selank on gastric wall blood flow and mesenteryc lymphatic vessels contractility in anesthetized rats].

Pavlov TS, Sanzhieva LTs, Samonina GE, Sergeev VI, Lelekova TV.

Ross Fiziol Zh Im I M Sechenova. 2005 Feb;91(2):178-83. Russian.

PMID:
15835541
45.

A new property of endogenous immunostimulator Taftsin.

Pavlov TS, Samonina GE.

Bull Exp Biol Med. 2004 Aug;138(2):163-4.

PMID:
15662460
46.

A new property of the synthetic anxiolytic Selank and its derivatives.

Pavlov TS, Samonina GE, Andreeva LA, Myasoedov NF, Ashmarin IP.

Dokl Biol Sci. 2004 Jul-Aug;397:281-3. No abstract available.

PMID:
15508574
47.

A systematic approach to simulating metabolism in computational toxicology. I. The TIMES heuristic modelling framework.

Mekenyan OG, Dimitrov SD, Pavlov TS, Veith GD.

Curr Pharm Des. 2004;10(11):1273-93. Review.

PMID:
15078141
48.

[Indications for and the postoperative results of mitral valve prosthesis].

Tomov I, Savova A, Chirkov A, Dragoĭchev Ch, Pavlov Ts.

Vutr Boles. 1988;27(6):88-93. Bulgarian.

PMID:
3247713
49.

[Analysis of the autopsy data on 48 cases of infectious endocarditis in patients over 14].

Prodanov A, Boiadzhiev K, Khekimian A, Kharizanov R, Pavlov Ts.

Vutr Boles. 1987;26(1):33-7. Bulgarian.

PMID:
3590725
50.

[Pregnancy, labor and puerperal problems of women with acquired heart defects].

Pavlov Ts, Khekimian A, Klinkachev A, Irasek V.

Vutr Boles. 1986;25(1):41-8. Bulgarian.

PMID:
3716361

Supplemental Content

Loading ...
Support Center